Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | SNCA | P37840 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.34 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.34 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21916391 | 0.88 | CYP19A1 (0.44) | MAPTSNCACYP19A1HSD17B1HSD17B2 | |
| SCHEMBL21915587 | 0.86 | CYP19A1 (0.36) | MAPTCYP19A1HSD17B1HSD17B2 | |
| SCHEMBL21915242 | 0.85 | HSD17B1 (0.32) | CYP19A1HSD17B1HSD17B2 | |
| SCHEMBL21915473 | 0.84 | CYP19A1 (0.41) | MAPTSNCACYP19A1HSD17B1HSD17B2 | |
| SCHEMBL21915617 | 0.83 | HSD17B1 (0.36) | MAPTSNCACYP19A1HSD17B1HSD17B2 | |
| SCHEMBL21916407 | 0.82 | MAPT (0.34) | MAPTSNCACYP19A1HSD17B1HSD17B2 | |
| SCHEMBL21915614 | 0.81 | HSD17B1 (0.36) | MAPTSNCACYP19A1HSD17B1HSD17B2 | |
| SCHEMBL21915581 | 0.81 | HSD17B1 (0.41) | MAPTSNCACYP19A1HSD17B1HSD17B2 | |
| SCHEMBL21915234 | 0.81 | HSD17B1 (0.43) | MAPTSNCACYP19A1HSD17B1HSD17B2 | |
| SCHEMBL21915616 | 0.81 | CYP19A1 (0.38) | MAPTSNCACYP19A1HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020062375-A1 | 1,2,4-THIADIAZOLE COMPOUNDS AND PREPARATION METHOD THEREFOR AND USE THEREOF | 武汉尚赛光电科技有限公司 | 2020-04-02 | — | — | WO | disclosed |